Von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome

Platelets

Volumn 9, Issue 3-4, 1998, Pages 155-159

  Bath, P M W ^a,c   Blann, A ^b   Smith, N ^a   Butterworth, R J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ACUTE PHASE RESPONSE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STROKE; THROMBOCYTE FUNCTION;

EID: 0031809284     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109876618     Document Type: Conference Paper

References (35)

1. Horowitz DR, Tuhrim S, Weinberger JM, Rudolph SH. Mechanisms in lacunar infarction. Stroke 1992; 23: 325-7.
2. Shah AB, Beamer N, Coull BM. Enhanced in vivo platelet activation in subtypes of ischemic stroke. Stroke 1985; 16: 643-7.
3. Butterworth RJ, Bath PMW. Mean platelet volume (MPV) in acute ischaemic stroke. Cerebrovasc Dis 1996; 6 (suppl. 2): 18 (abstract).
4. Kilpatrick TJ, Matkovic Z, Davis SM, McGrath CM, Dauer RJ. Hematologic abnormalities occur in both cortical and lacunar infarction. Stroke 1993; 24: 1945-50.
5. Takano K, Yamaguchi T, Okada Y, Uchida K, Kisiel W, Kato H. Hypercoagubility in acute ischemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method. Thromb Res 1990; 58: 481-91.
6. Mulley GP, Heptinstall S, Taylor PM, Mitchell JRA. ADP induced platelet release reaction in acute stroke. Thromb Haemostas 1983; 50: 524-6.
7. Gaur SPS, Garg RK, Agarwal S, Kar AM, Srimal RC. Platelet functions and lipid profile within 24 hours following an attack of TIA, thrombotic and haemorrhagic stroke. Indian J Med Res 1994; 99: 259-63.
8. Liu L, Lin Z, Shen Z. Changes in von Willebrand factor and antithrombin III levels in acute stroke: difference between thrombotic and haemorrhagic stroke. Thromb Res 1993; 72: 353-8.
9. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haem 1995; 90: 244-8.
10. Lip GYH. Fibrinogen and cardiovascular disorders. Q J Med 1995; 88: 155-65.
11. Blann AD, Lip GYH. Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997; 128: 135-8.
12. Bath PMW, Butterworth RJ, Soo J, Kerr JE. The King's College Hospital Acute Stroke Unit. J Royal College Physicians (London) 1996; 30: 13-7.
13. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-6.
14. Rankin J. Cerebral vascular accidents in patients over the age of 60.2. Prognosis. Scot Med J 1957; 2: 200-15.
15. Blann AD, Jackson P, Bath PMW, Watts GF. von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. J Int Med 1995; 237: 557-61.
16. Siegel S, Castellan NJ. Nonparametric Statistics for the Behavioral Sciences, 2nd edn. Singapore: McGraw-Hill, 1988: 1-399.
17. Bath PMW, Butterworth RJ, Soo J, Kerr J. Do Acute stroke units improve care? Cerebrovasc Dis 1996; 6: 346-9.
18. Catto AJ, Carter AM, Barrett JH, Bamford J, Rice PJ, Grant PJ. Von Willebrand factor and factor VIII:C in acute cerebrovascular disease. Thromb Haemostas 1997; 77: 1104-08.
19. Eisenberg S. Blood viscosity and fibrinogen concentration following cerebral infarction. Circulation 1966; 33/34: 10-14.
20. Mistry P, Chawla KP, Rai HP, Jaiswal P. Plasma fibrinogen levels in stroke. J Postgrad Med 1990; 36: 1-4.
21. D'Erasmo E, Acca M, Celi FS, Medici F, Palmerini T, Pisani D. Plasma fibrinogen and platelet count in stroke. J Int Med 1993; 24: 185-91.
22. Resch KL, Ernst E, Matrai A, Paulsen HF. Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors. Ann Intern Med 1992; 117: 371-5.
23. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-5.
24. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258: 1183-6.
25. Ernst E. Plasma fibrinogen - an independent cardiovascular risk factor. J Int Med 1990; 227: 365-72.
26. Hart RG, Kanter MC. Hematologic disorders and ischaemic stroke. A selective review. Stroke 1990; 21: 1111-21.
27. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ, Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haem 1994; 88: 601-7.
28. Blann AD, Von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci 1993; 50: 125-34.
29. Blann AD, Dobrotova M, Kubisz P, McCollum CN. Von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost as 1995; 74: 626-30.
30. Bath PMW. Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blond Coag Fibrinol 1996; 7: 157-61.
31. International Stroke Trial Collaborative Group. The International Stroke Trial (1ST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569-81.
32. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 1997; 349: 1641-9.
33. Smith N, Blann A, Butterworth R, Bath P. Von Willebrand factor, P-selectin and fibrinogen in acute stroke. Eur J Clin Invest 1997; 27 (suppl. 1): A22.
34. Zheng L. Increased factor VIII related antigen in cerebral thrombosis. Thromb Res 1983; 32: 321-4.
35. Zarafis J, Blann AD, Farooqi IS, Sagar G, Beevers DG, Lip GYH. Increased soluble adhesion molecule P-selectin, von Willebrand factor and fibrinogen in acute stroke. Evidence for early endothelial and haemorheological dysfunction. Clin Sci 1996; 90: 27P.